Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Orphazyme (NASDAQ: ORPH ) and ORPH stock are seeing impressive gains. Shares of this biopharma company are currently up more than 4% at the time of writing on a very green day in the over...
Trillium Therapeutics (NASDAQ:TRIL) +191% after acquisition by Pfizer for $2.3B Vivos Therapeutics (NASDAQ:VVOS) +61% on FDA 510k clearance for sleep apnea treatment device Xeris Pharmaceuticals (NASDAQ:XERS) +48% announces approval of supplemental new drug Application (sN...
Gainers: CohBar (NASDAQ:CWBR) +42%, Allied Healthcare Products AHPI +24%, Doximity DOCS +22%, Orphazyme (NASDAQ:ORPH) +13%, Fulcrum Therapeutics FULC +13%. Losers: Biodesix (NASDAQ:BDSX) -19%, Inari Medical (NASDAQ:NARI) -16%, Berkeley Li...
CohBar (NASDAQ:CWBR) +62% on Q2 earnings Good Times Restaurant (NASDAQ:GTIM) +32% on Q3 earnings Upstart Holdings (NASDAQ:UPST) +22% on Q2 earnings Mogo (NASDAQ:MOGO) +20% on Q2 earnings fuboTV (NYSE:FUBO) +16% on Q2 earnings Lantern Pharma (N...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, some significant buzz is building around biopharmaceutical company Orphazyme (NASDAQ: ORPH ). Indeed, ORPH stock is currently up big today on high volume as investors pile into this play. Currently, investors i...
Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +123%. Lightning eMotors (NYSE:ZEV) +52%. 3D Systems (NYSE:DDD) +41%. MediaCo (NASDAQ:MDIA) +40%. Allied Healthcare Products (NASDAQ:AHPI) +27%. Exagen (NASDAQ:XGN) +26%. IMV (NASDAQ:IMV) +23%. Arcturus Therapeutics (NASDAQ:ARCT) +21%. Orphazyme A/S...
Gaiers: TD Holdings (GLG) +45%.GX Acquisition (GXGX) +40%.China SXT Pharmaceuticals (SXTC) +35%.Newegg Commerce (NEGG) +17%.Orphazyme (ORPH) +17%.TDH Holdings (PETZ) +16%.Aehr Test Systems (AEHR) +14%.Byrna Technologies (BYRN) +13%.Jewett-Cameron Trading Company (JCTCF) +13%.CooTek (Cayman) (...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Small biotech companies such as Denmark’s Orphazyme (NASDAQ: ORPH ) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago ...
OCALA, Fla., July 09, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has signed a contract to sponsor a Phase 2a Human Challenge Trial (HCT) to test the company’s drug Ampligen as a potential intranasal antiviral therapy using a human Rhinov...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s an argument to be made that all of the recent movement in Orphazyme (NASDAQ: ORPH ) is simply a sign of the times. Even if it isn’t, there’s little reason to invest in ORPH stock now. T...
News, Short Squeeze, Breakout and More Instantly...
Orphazyme A/S Company Name:
ORPH Stock Symbol:
NASDAQ Market:
(NewsDirect) hVIVO PLC (AIM:HVO) chief executive Yamin 'Mo' Khan discusses the company's record-breaking financial results in 2023 in an interview with Proactive's Stephen Gunnion. hVIVO announced a 16% year-on-year growth in revenue, reaching £56 million, with an EBITDA margin i...
(NewsDirect) hVIVO chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions whil...
(NewsDirect) hVIVO PLC (AIM:HVO) Chief Scientific Officer Andrew Catchpole speaks to Steve Darling from Proactive after the specialist contract research organisation announced it has secured a £6.3 million contract with a biotechnology client for the testing of their antiviral candid...